Age, gender, tumor grade, stage at initial CRC diagnostic, T stage, N stage, interval between metastases and PT diagnosis, interval between BM and PT diagnosis, interval between BM and ECM diagnosis, RAS status, BRAF status and MMR status were not associated with CD3 T-cell infiltration in PTs (Table 2). The gene discussed is BRAF; the disease is colorectal carcinoma.